These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38188199)

  • 41. Efficacy of Angiotensin-Converting Enzyme Inhibitors and Angiotensin-Receptor Blockers in Coronary Artery Disease without Heart Failure in the Modern Statin Era: a Meta-Analysis of Randomized-Controlled Trials.
    Hoang V; Alam M; Addison D; Macedo F; Virani S; Birnbaum Y
    Cardiovasc Drugs Ther; 2016 Apr; 30(2):189-98. PubMed ID: 26861251
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nurse-led titration of angiotensin converting enzyme inhibitors, beta-adrenergic blocking agents, and angiotensin receptor blockers for people with heart failure with reduced ejection fraction.
    Driscoll A; Currey J; Tonkin A; Krum H
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD009889. PubMed ID: 26689943
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Comparative Study of the Safety and Efficacy Between Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on the Management of Hypertension: A Systematic Review.
    Peresuodei TS; Gill A; Orji C; Reghefaoui M; Saavedra Palacios MS; Nath TS
    Cureus; 2024 Feb; 16(2):e54311. PubMed ID: 38496070
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cardiovascular effects of angiotensin converting enzyme inhibition or angiotensin receptor blockade in hemodialysis: a meta-analysis.
    Tai DJ; Lim TW; James MT; Manns BJ; Tonelli M; Hemmelgarn BR;
    Clin J Am Soc Nephrol; 2010 Apr; 5(4):623-30. PubMed ID: 20133488
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of traditional Chinese medicine
    Ma S; Jiang Y; Qian L; Wang M; Xu S; Wang G
    Front Pharmacol; 2024; 15():1374377. PubMed ID: 38576485
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative Effectiveness of Combination Therapy with Statins and Angiotensin-Converting Enzyme Inhibitors versus Angiotensin II Receptor Blockers in Patients with Coronary Heart Disease: A Nationwide Population-Based Cohort Study in Korea.
    Lee J; Lee S
    Pharmacotherapy; 2018 Nov; 38(11):1095-1105. PubMed ID: 30225928
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Angiotensin Receptor Blockers as an Alternative to Angiotensin-Converting Enzyme Inhibitors in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention.
    Lim S; Choo EH; Choi IJ; Ihm SH; Kim HY; Ahn Y; Chang K; Jeong MH; Seung KB
    J Korean Med Sci; 2019 Nov; 34(45):e289. PubMed ID: 31760711
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Divergent Cardiovascular Effects of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Myocardial Infarction and Death.
    Strauss MH; Hall AS
    Prog Cardiovasc Dis; 2016; 58(5):473-82. PubMed ID: 26586276
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Meta-analysis of the association between angiotensin pathway inhibitors and COVID-19 severity and mortality.
    Fernando ME; Drovandi A; Golledge J
    Syst Rev; 2021 Sep; 10(1):243. PubMed ID: 34488897
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Angiotensin receptor blockers for heart failure.
    Heran BS; Musini VM; Bassett K; Taylor RS; Wright JM
    Cochrane Database Syst Rev; 2012 Apr; 2012(4):CD003040. PubMed ID: 22513909
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of Renin-Angiotensin System Inhibitors on Mortality and Disease Severity of COVID-19 Patients: A Meta-analysis of Randomized Controlled Trials.
    Yin J; Wang C; Song X; Li X; Miao M
    Am J Hypertens; 2022 May; 35(5):462-469. PubMed ID: 35512430
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers Use and COVID-19 Infection Among 824 650 Patients With Hypertension From a US Integrated Healthcare System.
    An J; Wei R; Zhou H; Luong TQ; Gould MK; Mefford MT; Harrison TN; Creekmur B; Lee MS; Sim JJ; Brettler JW; Martin JP; Ong-Su AL; Reynolds K
    J Am Heart Assoc; 2021 Feb; 10(3):e019669. PubMed ID: 33307964
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy and safety of combination therapy with sodium-glucose cotransporter 2 inhibitors and renin-angiotensin system blockers in patients with type 2 diabetes: a systematic review and meta-analysis.
    Tian B; Deng Y; Cai Y; Han M; Xu G
    Nephrol Dial Transplant; 2022 Mar; 37(4):720-729. PubMed ID: 33605424
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Use Associated with Reduced Mortality and Other Disease Outcomes in US Veterans with COVID-19.
    Rizk JG; Wenziger C; Tran D; Hashemi L; Moradi H; Streja E; Ahluwalia A
    Drugs; 2022 Jan; 82(1):43-54. PubMed ID: 34914085
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular outcomes in hypertensive patients with type 2 diabetes mellitus: A PRISMA-compliant systematic review and meta-analysis.
    Lv X; Zhang Y; Niu Y; Song Q; Zhao Q
    Medicine (Baltimore); 2018 Apr; 97(15):e0256. PubMed ID: 29642146
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association between angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and community-acquired pneumonia: A nationwide population propensity-score matching study.
    Lin SY; Chang SS; Lin CL; Lin CC; Hsu WH; Chou CH; Chi CY; Lin CD; Tu CY; Hsu CY; Kao CH
    Int J Clin Pract; 2021 Oct; 75(10):e14476. PubMed ID: 34107133
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans.
    Derington CG; Cohen JB; Mohanty AF; Greene TH; Cook J; Ying J; Wei G; Herrick JS; Stevens VW; Jones BE; Wang L; Zheutlin AR; South AM; Hanff TC; Smith SM; Cooper-DeHoff RM; King JB; Alexander GC; Berlowitz DR; Ahmad FS; Penrod MJ; Hess R; Conroy MB; Fang JC; Rubin MA; Beddhu S; Cheung AK; Xian W; Weintraub WS; Bress AP
    PLoS One; 2021; 16(4):e0248080. PubMed ID: 33891615
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of angiotensin-converting enzyme inhibitors or receptor blockers is associated with reduced mortality in patients with post-acute kidney injury: meta-analysis.
    Shi H; Peng Q; Zhou XL; Zhu SP; Sun SY
    Eur Rev Med Pharmacol Sci; 2021 Aug; 25(15):4900-4908. PubMed ID: 34355362
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Accepting Medication Therapy Management Recommendations to Add ACEIs or ARBs in Diabetes Care.
    Hurwitz JT; Grizzle AJ; Augustine J; Rehfeld R; Wild A; Abraham I
    J Manag Care Spec Pharm; 2016 Jan; 22(1):40-8. PubMed ID: 27015050
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prior Use of Angiotensin-converting Enzyme Inhibitors or Angiotensin II Receptor Blockers and Clinical Outcomes of Sepsis and Septic Shock: A Systematic Review and Meta-analysis.
    Shrestha DB; Sedhai YR; Oli PR; Proskuriakova E; Adelkhanova A; Shtembari J; Khan TMA; Singh K; Ahmed MA; Waheed I; Kazimuddin N; Steff R; Acharya R; Patel NK
    J Cardiovasc Pharmacol; 2024 Jan; 83(1):16-22. PubMed ID: 37815234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.